Vitamin K Administration: Route Selection, Dosing, and Safety

Preferred Routes for Most Clinical Situations

• The American College of Cardiology (ACC) states that oral vitamin K is the preferred route for the majority of indications because it offers a superior safety profile and predictable effectiveness; intravenous (IV) administration should be reserved for life‑threatening bleeding that requires rapid reversal. 1
• For adult patients requiring warfarin reversal without active major bleeding, the ACC recommends oral vitamin K as the treatment of choice. 2

Oral Vitamin K Efficacy and Dosing in Warfarin Reversal

• Oral vitamin K provides a predictable and effective reduction in INR within 24 hours, offering convenience and safety compared with parenteral routes. 5
• A single oral dose of 1–2.5 mg reliably lowers INR values ranging from 4 to 10 to safe levels within 24 hours. 2
• When the INR is 5–9, the ACC advises an oral dose of 1–2.5 mg; when the INR exceeds 9, a higher oral dose of 3–5 mg is recommended. 2

Indications for Intravenous Vitamin K

• IV vitamin K is indicated only for serious bleeding or major warfarin overdose (INR > 20) where rapid reversal is essential. 7
• IV vitamin K is also indicated in any life‑threatening bleeding situation. 9

Intravenous Administration Technique and Rapid Reversal

• The ACC requires IV vitamin K to be administered by slow infusion (5–10 mg diluted in 25–50 mL normal saline over 15–30 minutes) to minimize the risk of anaphylaxis. 2
• According to the 2020 ACC guidelines, this slow IV infusion produces a more rapid and predictable INR reduction (4–6 hours) compared with oral administration (18–24 hours). 1

Safety Considerations

• The ACC advises complete avoidance of the subcutaneous route for vitamin K because absorption is unpredictable and the response may be delayed. 5
• IV vitamin K carries a risk of anaphylaxis; administering the drug slowly (as described above) reduces this risk. 1
• High‑dose vitamin K (10 mg) can induce transient warfarin resistance lasting up to one week; therefore, the minimum effective dose should be used. 5

Dosing for Major Bleeding or Life‑Threatening Situations

• In major bleeding or life‑threatening scenarios, the ACC recommends IV vitamin K 10 mg given by slow infusion in conjunction with prothrombin complex concentrate or fresh frozen plasma. 7
• The IV dose may be repeated every 12 hours if ongoing reversal is required. 7